These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 32941398)
21. Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs. Vohora D; Saraogi P; Yazdani MA; Bhowmik M; Khanam R; Pillai KK Drugs Today (Barc); 2010 Apr; 46(4):265-77. PubMed ID: 20502724 [TBL] [Abstract][Full Text] [Related]
22. Novel medications for epilepsy. Fattore C; Perucca E Drugs; 2011 Nov; 71(16):2151-78. PubMed ID: 22035515 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs. Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359 [TBL] [Abstract][Full Text] [Related]
24. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting. Sanmartí-Vilaplana F; Díaz-Gómez A Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216 [TBL] [Abstract][Full Text] [Related]
25. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Contin M; Riva R; Albani F; Avoni P; Baruzzi A Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622 [TBL] [Abstract][Full Text] [Related]
26. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain. Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979 [TBL] [Abstract][Full Text] [Related]
28. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs. Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629 [TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice. Verrotti A; Lattanzi S; Brigo F; Zaccara G Epilepsy Behav; 2020 Mar; 104(Pt A):106939. PubMed ID: 32058303 [TBL] [Abstract][Full Text] [Related]
30. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database. Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907 [TBL] [Abstract][Full Text] [Related]
31. Pharmacologic intervention and treatment of childhood seizure disorders: relative efficacy and safety of antiepileptic drugs. Bourgeois BF Epilepsia; 1994; 35 Suppl 2():S18-23. PubMed ID: 8275977 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic Drug Monitoring for Rufinamide in Japanese Patients With Epilepsy: Focus on Drug Interactions, Tolerability, and Clinical Effectiveness. Yamamoto Y; Inoue Y; Usui N; Imai K; Kagawa Y; Takahashi Y Ther Drug Monit; 2022 Aug; 44(4):585-591. PubMed ID: 35213526 [TBL] [Abstract][Full Text] [Related]
33. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort. McGinnis E; Kessler SK Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide. Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655 [TBL] [Abstract][Full Text] [Related]
35. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region. Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846 [TBL] [Abstract][Full Text] [Related]
38. Effect of CYP Inducers/Inhibitors on Topiramate Concentration: Clinical Value of Therapeutic Drug Monitoring. Yamamoto Y; Takahashi Y; Imai K; Kagawa Y; Inoue Y Ther Drug Monit; 2017 Feb; 39(1):55-61. PubMed ID: 27941476 [TBL] [Abstract][Full Text] [Related]
39. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study. Kalilani L; Lu C; Pierre-Louis B; Gold M Epilepsy Behav; 2017 Jul; 72():51-57. PubMed ID: 28575767 [TBL] [Abstract][Full Text] [Related]
40. [The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy]. Barcs Gábor ; Szűcs A; Horváth A; Kamondi A Ideggyogy Sz; 2015 Jan; 68(1-2):23-9. PubMed ID: 25842913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]